Nathaniel S. Gardiner

2020

In 2020, Nathaniel S. Gardiner earned a total compensation of $1.8M as Senior Vice President and General Counsel at Enanta Pharmaceuticals, a 20% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$169,470
Option Awards$981,504
Salary$431,025
Stock Awards$187,821
Other$19,171
Total$1,788,991

Gardiner received $981.5K in option awards, accounting for 55% of the total pay in 2020.

Gardiner also received $169.5K in non-equity incentive plan, $431K in salary, $187.8K in stock awards and $19.2K in other compensation.

Rankings

In 2020, Nathaniel S. Gardiner's compensation ranked 6,035th out of 13,090 executives tracked by ExecPay. In other words, Gardiner earned more than 53.9% of executives.

ClassificationRankingPercentile
All
6,035
out of 13,090
54th
Division
Manufacturing
2,484
out of 5,617
56th
Major group
Chemicals And Allied Products
995
out of 2,248
56th
Industry group
Drugs
861
out of 1,948
56th
Industry
Pharmaceutical Preparations
641
out of 1,453
56th

Pay ratio

Nathaniel S. Gardiner's Pay$1,788,991
Median Employee's Pay$232,629
Pay Ratio

8

to 1

In 2020, the annual total compensation of Nathaniel S. Gardiner was $1,788,991.

The annual total compensation of the median employee at Enanta Pharmaceuticals was $232,629.

The ratio of Nathaniel S. Gardiner's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on January 21, 2021.

Gardiner's colleagues

We found four more compensation records of executives who worked with Nathaniel S. Gardiner at Enanta Pharmaceuticals in 2020.

2020

Jay Luly

Enanta Pharmaceuticals

Chief Executive Officer

2020

Yat Or

Enanta Pharmaceuticals

Chief Scientific Officer

2020

Nathalie Adda

Enanta Pharmaceuticals

Chief Medical Officer

2020

Paul Mellett

Enanta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like